Here's the latest
Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2023 – Oct 2025Where it's discussed
-
News54 articles
-
Facebook6 posts
-
Bluesky4 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several discussions highlight the relevance of recent research, such as the impact of the COVID-19 pandemic on the severity at diagnosis, with phrases like 'severity at the start' and 'impact on future outcomes' indicating concern and recognition of the article's importance. The tone is generally respectful and acknowledges the ongoing challenge of managing Type 1 Diabetes in youth, reflecting moderate interest and engagement.
Most discussions acknowledge the importance of the publication, especially noting the significance of early diagnosis and advancements in treatments.
The posts demonstrate some interest, as they reference historical milestones and current research, but do not heavily delve into detailed analysis.
There is a moderate level of engagement, with references to specific studies and broader implications, but little in-depth critique or discussion.
The overall tone suggests the publication influences ongoing research and clinical awareness, but doesn’t indicate a dramatic or transformative impact yet.
Abstract in brief
- The statement explains that Type 1 Diabetes is a chronic condition commonly diagnosed in children and adolescents, where the body's immune system attacks insulin-producing cells in the pancreas.
- It emphasizes the importance of early diagnosis, proper management, and continuous monitoring to prevent complications and improve quality of life for young patients.
- The document also highlights advancements in treatment options, such as insulin therapies and technology, and stresses the need for ongoing research and support for affected families.]
Top posts
Most liked on X and BlueskyToday is #ClinicalTrialsDay! Recognized as the day in 1747 that James Lind, a ship’s surgeon in the British Royal Navy, started what is considered to be the first randomized clinical trial. Our Type 1 Diabetes research team reflects on how they see the work they're doing today impacting the future.
Endocrinología, Diabetes y Nutrición: Gravedad al comienzo de la diabetes tipo 1 en niños y adolescentes durante la pandemia por la enfermedad por coronavirus-19: TITLE Severity of new-onset type 1 diabetes in children and adolescents during the coronavirus-19… #ThatCovidLife #CovidIsNotOver
Increased Severity of New-onset Type 1 Diabetes in Children and Adolescents during the COVID-19 Pandemic: Experience from a Tertiary Care Center in Serbia https://www.medrxiv.org/content/10.1101/2023.11.20.23298741v1
All mentions
Effective Weight Loss Strategies for People with Type 1 Diabetes
Can you lose weight with type 1 diabetes? Yes, but it requires a safe, specific approach. This video explains how weight loss works with T1D, focusing on managing insulin, food, and exercise safely to improve health…
Low Carb Diets for Children with Type 1 Diabetes: Scientific Insights and Risks
Many parents hear that reducing carbs may help control type 1 diabetes. This video explains what a low carb diet is, the goals families have, scientific evidence on benefits, and potential risks that require attention.
Here's the latest
Today is #ClinicalTrialsDay! Recognized as the day in 1747 that James Lind, a ship’s surgeon in the British Royal Navy, started what is considered to be the first randomized clinical trial. Our Type 1 Diabetes research team reflects on how they see the work they're doing today impacting the future.
Endocrinología, Diabetes y Nutrición: Gravedad al comienzo de la diabetes tipo 1 en niños y adolescentes durante la pandemia por la enfermedad por coronavirus-19: TITLE Severity of new-onset type 1 diabetes in children and adolescents during the coronavirus-19… #ThatCovidLife #CovidIsNotOver
Increased Severity of New-onset Type 1 Diabetes in Children and Adolescents during the COVID-19 Pandemic: Experience from a Tertiary Care Center in Serbia https://www.medrxiv.org/content/10.1101/2023.11.20.23298741v1